Literature DB >> 17233543

Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells.

Saba Parsa1, Blaine Pfeifer.   

Abstract

Bacterial vectors offer a biological route to gene and protein delivery with this article featuring delivery to antigen-presenting cells (APCs). Primarily in the context of immune stimulation against infectious disease or cancer, the goal of bacterially mediated delivery is to overcome the hurdles to effective macromolecule delivery. This review will present several bacterial vectors as macromolecule (protein or gene) delivery devices with both innate and acquirable (or engineered) biological features to facilitate delivery to APCs. The review will also present topics related to large-scale manufacture, storage, and distribution that must be considered if the bacterial delivery devices are ever to be used in a global market.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17233543     DOI: 10.1021/mp0600889

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  A comparison between polymeric microsphere and bacterial vectors for macrophage P388D1 gene delivery.

Authors:  Saba Parsa; Yong Wang; Jason Fuller; Robert Langer; Blaine A Pfeifer
Journal:  Pharm Res       Date:  2008-03-15       Impact factor: 4.200

2.  Hybrid biosynthetic gene therapy vector development and dual engineering capacity.

Authors:  Charles H Jones; Anitha Ravikrishnan; Mingfu Chen; Ryan Reddinger; Mahmoud Kamal Ahmadi; Snehal Rane; Anders P Hakansson; Blaine A Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

3.  Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene delivery.

Authors:  Charles H Jones; Akhila Gollakota; Mingfu Chen; Tai-Chun Chung; Anitha Ravikrishnan; Guojian Zhang; Blaine A Pfeifer
Journal:  Biomaterials       Date:  2015-05-11       Impact factor: 12.479

4.  Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice.

Authors:  Ascención Torres-Escobar; María Dolores Juárez-Rodríguez; Bronwyn M Gunn; Christine G Branger; Steven A Tinge; Roy Curtiss
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 5.  Enhancing vaccine effectiveness with delivery technology.

Authors:  Marie Beitelshees; Yi Li; Blaine A Pfeifer
Journal:  Curr Opin Biotechnol       Date:  2016-03-06       Impact factor: 9.740

6.  A gene-based avian influenza vaccine in poultry.

Authors:  S S Rao; D Styles; W Kong; C Andrews; J P Gorres; G J Nabel
Journal:  Poult Sci       Date:  2009-04       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.